AstraZeneca PLC

The European Union needs to be faster in its efforts to vaccinate people against the coronavirus, the 27 heads of state said on Thursday.

Rocket builder Astra is preparing to go public via a SPAC in the second quarter, with CEO Chris Kemp telling CNBC how the company plans to scale its business.

Dr. Peter Hotez warned that people should not become complacent due to dropping Covid cases, especially amid reports of B.1.526 spreading in New York.

The news is a hopeful turning point for poorer countries that risk being left behind in the global race for vaccinations.

“We’ve been in the process of developing a manufacturing process for a vaccine product that we’ve never made before,” Pfizer Chief Business Officer John Young said.

U.K. Prime Minister Boris Johnson on Monday announced his plan for the lifting of lockdown restrictions in England.

The lockdown easing for England will come in a number of steps and will be data dependent at every stage, the British prime minister said.

The U.S. Food and Drug Administration is expected to authorize Johnson & Johnson’s vaccine in the coming weeks.

CEO Adar Poonawalla made the announcement over Twitter but did not explain who gave the direction.

Even before COVID-19, India produced up to about 60% of the world’s vaccines and can do so at a relatively low cost.

Check out the companies making headlines in midday trading.

The rollout of COVID-19 vaccines has been slower and more difficult than Americans had hoped, plagued by an undersupply that the Biden administration is trying to overcome. The new administration announced on Feb. 11 that it had finalized a deal to buy 200 million more doses of the Pfizer BioNTech and Moderna versions of the vaccine, the first to receive…

Ahead of Friday’s trading, Wall Street was tracking for a second straight positive week, in a continuation of February’s strength.

The stocks making the biggest moves in premarket trading include Disney, Coherent, SurveyMonkey, and more.

European stocks closed higher on Thursday as traders digested fresh corporate results and amid more muted trade in Asia Pacific due to the Lunar New Year.

AstraZeneca has featured prominently in 2020 because of its coronavirus vaccine, although it has said will not profit from the inoculations during the pandemic.

Drugmaker AstraZeneca is now racing to adapt its Covid-19 vaccine in the face of the new variants.

European stocks closed higher Monday with markets tracking positive sentiment in Asia and the U.S.

Dow futures rose Monday, in an advance that would exceed the 30-stock average’s closing record.

Drugmaker AstraZeneca is racing to adapt its Covid-19 vaccine in the face of new variants of the virus.